5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY

Background: Glycocalyx is a glycoprotein layer protecting the capillary endothelium. An impaired glycocalyx may precede the development of microvascular complications in diabetes. Capillaroscopy is a new method to estimate the dimensions of the glycocalyx by measuring the perfused boundary region (P...

Full description

Bibliographic Details
Main Author: Signe Abitz Winther
Format: Article
Language:English
Published: Atlantis Press 2017-12-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930219/view
id doaj-583be7e0a90842cfb844535a8204b47c
record_format Article
spelling doaj-583be7e0a90842cfb844535a8204b47c2020-11-25T01:28:31ZengAtlantis PressArtery Research 1876-44012017-12-012010.1016/j.artres.2017.10.0485.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHYSigne Abitz WintherBackground: Glycocalyx is a glycoprotein layer protecting the capillary endothelium. An impaired glycocalyx may precede the development of microvascular complications in diabetes. Capillaroscopy is a new method to estimate the dimensions of the glycocalyx by measuring the perfused boundary region (PBR). We evaluated the glycocalyx thickness in type 1 diabetic patients with different levels of historical and current albuminuria. Methods: Cross-sectional study including 77 type 1 diabetics stratified by history of normoalbuminuria (<30 mg/g; n = 26), microalbuminuria (30–299 mg/g; n = 27) and macroalbuminuria (>300 mg/g; n = 24). Glycocalyx thickness was assessed by 5 measurements with the GlycoCheck® device, a non-invasive hand-held microscope generating video recordings of the sublingual capillaries. Endothelial glycocalyx thickness was estimated from the PBR in capillaries with a diameter range of 5–25 μm. Higher PBR indicates smaller glycocalyx width. Urinary albumin-to-creatinine ratio (UACR) was measured in 3 morning samples. Results: In normo-, micro-, and macroalbuminurics PBR was (mean ± SD) 2.30 ± 0.22 μm, 2.32 ± 0.25 μm, and 2.49 ± 0.35 μm, respectively. Differences between normo- and macroalbuminurics and micro- and macroalbuminurics were significant (p < 0.05) in an unadjusted model and remained significant after adjustment for age, sex, HbA1c, diabetes duration and systolic blood pressure. In pooled (n = 77) multivariate linear regression, higher level of current UACR was associated with a higher PBR (p = 0.0007). Conclusion: In type 1 diabetics with a history of macroalbuminuria, measurements with the non-invasive GlycoCheck® device revealed significantly higher PBR, suggesting an impaired glycocalyx, compared to patients with normo- or microalbuminuria. Moreover, higher current level of albuminuria was associated with higher PBR.https://www.atlantis-press.com/article/125930219/view
collection DOAJ
language English
format Article
sources DOAJ
author Signe Abitz Winther
spellingShingle Signe Abitz Winther
5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
Artery Research
author_facet Signe Abitz Winther
author_sort Signe Abitz Winther
title 5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
title_short 5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
title_full 5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
title_fullStr 5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
title_full_unstemmed 5.2 REDUCED SUBLINGUAL ENDOTHELIAL GLYCOCALYX IN TYPE 1 DIABETICS WITH DIABETIC NEPHROPATHY
title_sort 5.2 reduced sublingual endothelial glycocalyx in type 1 diabetics with diabetic nephropathy
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2017-12-01
description Background: Glycocalyx is a glycoprotein layer protecting the capillary endothelium. An impaired glycocalyx may precede the development of microvascular complications in diabetes. Capillaroscopy is a new method to estimate the dimensions of the glycocalyx by measuring the perfused boundary region (PBR). We evaluated the glycocalyx thickness in type 1 diabetic patients with different levels of historical and current albuminuria. Methods: Cross-sectional study including 77 type 1 diabetics stratified by history of normoalbuminuria (<30 mg/g; n = 26), microalbuminuria (30–299 mg/g; n = 27) and macroalbuminuria (>300 mg/g; n = 24). Glycocalyx thickness was assessed by 5 measurements with the GlycoCheck® device, a non-invasive hand-held microscope generating video recordings of the sublingual capillaries. Endothelial glycocalyx thickness was estimated from the PBR in capillaries with a diameter range of 5–25 μm. Higher PBR indicates smaller glycocalyx width. Urinary albumin-to-creatinine ratio (UACR) was measured in 3 morning samples. Results: In normo-, micro-, and macroalbuminurics PBR was (mean ± SD) 2.30 ± 0.22 μm, 2.32 ± 0.25 μm, and 2.49 ± 0.35 μm, respectively. Differences between normo- and macroalbuminurics and micro- and macroalbuminurics were significant (p < 0.05) in an unadjusted model and remained significant after adjustment for age, sex, HbA1c, diabetes duration and systolic blood pressure. In pooled (n = 77) multivariate linear regression, higher level of current UACR was associated with a higher PBR (p = 0.0007). Conclusion: In type 1 diabetics with a history of macroalbuminuria, measurements with the non-invasive GlycoCheck® device revealed significantly higher PBR, suggesting an impaired glycocalyx, compared to patients with normo- or microalbuminuria. Moreover, higher current level of albuminuria was associated with higher PBR.
url https://www.atlantis-press.com/article/125930219/view
work_keys_str_mv AT signeabitzwinther 52reducedsublingualendothelialglycocalyxintype1diabeticswithdiabeticnephropathy
_version_ 1725101128641675264